![Aligos Therapeutics Inc](/common/images/company/N_ALGS.png)
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's p... Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.05 | -16.0396039604 | 25.25 | 25.8411 | 20.12 | 348739 | 21.73391965 | CS |
4 | -12.94 | -37.9027533685 | 34.14 | 34.37 | 20.12 | 269109 | 24.81357 | CS |
12 | -1.41 | -6.236178682 | 22.61 | 46.8 | 20.12 | 364687 | 32.44874792 | CS |
26 | 6.15 | 40.8637873754 | 15.05 | 46.8 | 6.76 | 294938 | 24.31522604 | CS |
52 | 4.4725 | 26.7374084591 | 16.7275 | 46.8 | 6.76 | 362425 | 19.85929144 | CS |
156 | -38.05 | -64.2194092827 | 59.25 | 74.75 | 6.76 | 267315 | 26.90177795 | CS |
260 | -347.3 | -94.2469470828 | 368.5 | 937.7475 | 6.76 | 256513 | 119.0723813 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約